Results 101 to 110 of about 4,505 (178)

SMPDL3B a novel biomarker and therapeutic target in myalgic encephalomyelitis. [PDF]

J Transl Med
Rostami-Afshari B, Elremaly W, Franco A, Elbakry M, Akoume MY, Boufaied I, Moezzi A, Leveau C, Rompré P, Godbout C, Mella O, Fluge Ø, Moreau A.   +12 more
europepmc   +1 more source

Cardiovascular Disease and Diabetes: A New Challenge in the Treatment and Management. [PDF]

Int J Mol Sci
Riccioni G, Notarangelo C, Riccioni M, D'Orazio N.   +3 more
europepmc   +1 more source

Correction: SMPDL3B a novel biomarker and therapeutic target in myalgic encephalomyelitis. [PDF]

J Transl Med
Rostami-Afshari B, Elremaly W, Franco A, Elbakry M, Akoume MY, Boufaied I, Moezzi A, Leveau C, Rompré P, Godbout C, Mella O, Fluge Ø, Moreau A.   +12 more
europepmc   +1 more source

Trends in Adverse Event Reports of Dipeptidyl Peptidase-4 Inhibitor-Associated Pemphigoid in Japan. [PDF]

Drugs Real World Outcomes
Takami A, Terashima G, Tajima T, Yamashita K, Igarashi A.   +4 more
europepmc   +1 more source

Dipeptidyl Peptidase-4 Inhibitors Associated with Lower Psoriatic Disease Risk in Type 2 Diabetes: A 13-Year Nationwide Cohort Study with Mechanistic Validation. [PDF]

Acta Derm Venereol
Hung CT, Chung CH, Weng TH, Tsai CT, Chien WC, Chang YL.   +5 more
europepmc   +1 more source

Can DPP-4 Inhibitors Improve Glycemic Control and Preserve Beta-Cell Function in Type 1 Diabetes Mellitus? A Systematic Review. [PDF]

Diseases
Villa Chagas H, Laurindo LF, Dogani Rodrigues V, Haber JFDS, Chagas EFB, Barbalho SM.   +5 more
europepmc   +1 more source

Efficacy and safety of anti-prediabetic drugs in patients with prediabetes: a Bayesian network meta-analysis. [PDF]

BMC Med
Wu Y, Wang Z, Tuersun A, Yu Q, Zhong Y, Ali SSA, Liu H, Hu X, Zhang Y, Pang L, Li L, Gao L, Wu Q, Wang S, Cui M, Sun L, Wu Y, Yin A, Zhang L, Ma G.   +19 more
europepmc   +1 more source

Pharmacologic pitfalls in heart failure: A guide to drugs that may cause or exacerbate heart failure. A European Journal of Heart Failure expert consensus document. [PDF]

Eur J Heart Fail
Abdin A, Bauersachs J, Abdelhamid M, Aktaa S, Al Ghorani H, Bayes-Genis A, Biegus J, Böhm M, Butler J, Girerd N, Metra M, Mullens W, Skouri H, Vaduganathan M, El Hadidi S, Rosano GMC, Savarese G.   +16 more
europepmc   +1 more source

Enhancing evidence-based care using trial emulation in electronic health records: real-world effects of empagliflozin in people with type 2 diabetes. [PDF]

BMJ Open Diabetes Res Care
Ryan DK, Keogh RH, Williamson E, Lumbers RT, Diaz-Ordaz K, Shah AD, Bidulka P.   +6 more
europepmc   +1 more source

Association Between DPPs-4 Inhibitors and Bullous Pemphigoid: Reporting Odds Ratio Analysis Using EudraVigilance Database. [PDF]

Pharmaceuticals (Basel)
Pedrero AC, Aldea-Perona A.
europepmc   +1 more source